Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0275927
PubMed Identifier: 36327320
Publication URI: http://europepmc.org/abstract/MED/36327320
Type: Journal Article/Review
Volume: 17
Parent Publication: PloS one
Issue: 11
ISSN: 1932-6203